載入...
Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer
BACKGROUND: Single agent immune checkpoint inhibitors (ICIs) improve survival outcomes compared to chemotherapy for advanced non‐small cell lung cancer (NSCLC), but treatment efficacy widely varies. The combination of ICIs with chemotherapy has shown promising efficacy over chemotherapy alone; howev...
Na minha lista:
| 發表在: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons Australia, Ltd
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501017/ https://ncbi.nlm.nih.gov/pubmed/30950239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13057 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|